Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder

NCT01254305 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

262

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Levomilnacipran ER
DRUG: Paroxetine, Sertraline, Citalopram or Fluoxetine.
DRUG: Placebo

Sponsor

Forest Laboratories